Proteina Co., Ltd. (468530.KQ) stock: key figures, P/E, revenue and dividend

Health Care · South Korea

Price
57,000.00 KRW
Market cap
623.55 bn KRW
P/E (2025)
–
P/S (2025)
211.31
Dividend yield
0.00 %
Net margin
-305.39 %
Return on equity (ROE)
-31.76 %
Return on assets (ROA)
-28.38 %

Proteina Co., Ltd. financials

Fiscal year20242025
Revenue2.30 bn KRW2.95 bn KRW
Gross profit1.46 bn KRW1.54 bn KRW
Operating income-9.12 bn KRW-11.37 bn KRW
EBIT-2.68 bn KRW-8.90 bn KRW
Net income-5.73 bn KRW-9.01 bn KRW
Diluted EPS – continuing operations-531.71 KRW-823.80 KRW

Full history since 2022, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Proteina Co., Ltd.

Proteina Co., Ltd. develops protein-protein interaction profiling technology. The company offers technology that confirms the real-time activation of cancer signal pathways by directly seeing the relevant proteins, predicts the efficacy of drugs, and enables doctors to select which inhibitor to prescribe by confirming which bypass signal pathways are inducing resistance. It also offers single molecule protein interaction detection platform to analyze protein and protein-protein interaction (PPI) information. Proteina Co., Ltd. was founded in 2015 and is based in Seoul, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.